Key result
Serial NMR-derived S-TRLP is linked to ~57% lower heart failure risk in women versus men.
Why the study?
Lipid and metabolic biomarkers are increasingly implicated in HF progression, but their prognostic interpretation in female versus male patients remained unclear.
Do the prognostic associations between serially measured NMR-derived lipid and metabolic biomarkers and adverse clinical outcomes differ by biological sex in patients with heart failure?
Cohort (n=867)
Do the prognostic associations between serially measured NMR-derived lipid and metabolic biomarkers and adverse clinical outcomes differ by biological sex in patients with heart failure?
Serial NMR-derived lipid and metabolic biomarkers (specifically S-TRLP, HDLZ, and LP-IR) demonstrate sex-dependent prognostic associations with clinical outcomes in heart failure, showing more consistent prognostic value in men than in women.
Answers are grounded in this paper and cite their sources.
Sex-specific NMR lipid associations may refine HF risk stratification; leaves open causal and therapeutic implications pending trials.
Background Lipid and metabolic biomarkers are increasingly implicated in heart failure (HF) progression, yet their prognostic interpretation in female and male patients remains unclear. This study explored whether associations between serially measured nuclear magnetic resonance (NMR)-derived lipid and metabolic biomarkers and adverse clinical outcomes differed by biological sex in two prospective HF cohorts. Methods We analysed 397 chronic HF patients from Bio-SHiFT (113/284 women/men; mean age 64 years; 3,083 blood samples) and 470 patients hospitalized for HF from TRIUMPH (173/297 women/men; mean age 71 years; 2,031 blood samples). Median samples per patient were 9 (interquartile range [IQR], 5–11) and 4 (IQR, 3–6), respectively. Forty-five NMR-derived biomarkers were quantified using the Vantera ® system. Primary endpoints comprised cardiovascular death or worsening HF events in Bio-SHiFT and all-cause death or HF rehospitalization in TRIUMPH. Joint models combining serial biomarker measurements with time-to-event outcomes and including sex-by-biomarker interaction terms were fitted for all biomarkers in each cohort using unadjusted and multivariable-adjusted models. Cohort-specific interaction estimates were then pooled using fixed-effect meta-analysis, followed by false discovery rate correction. Sex-stratified joint models were used to characterize significant pooled signals. Results The primary endpoint occurred in 124 patients during median follow-up of 2.5 years (IQR, 2.1–2.7) in Bio-SHiFT and 186 during 1.0 year (IQR, 0.6–1.1) in TRIUMPH. After pooling cohort-specific estimates from the unadjusted interaction models, seven biomarkers remained FDR-significant: TRLP, M-TRLP, S-TRLP, TRL-TG, L-HDLP, HDLZ, and LP-IR. Three adjusted pooled interactions remained FDR-significant: S-TRLP (HR-interaction: 0.43, 95% confidence interval: 0.25–0.74), HDLZ (1.52, 1.16–1.98), and LP-IR (0.63, 0.47–0.84). For these three biomarkers, cohort-specific interaction estimates were directionally consistent, with lower or more inverse biomarker-endpoint associations in men for S-TRLP and LP-IR and a more positive association in men for HDLZ. Sex-stratified analyses showed more consistent associations among men, whereas estimates in women were generally closer to the null and less consistent across cohorts. Conclusions Serial NMR-derived lipid and metabolic biomarkers showed exploratory evidence of sex-dependent prognostic associations in HF, with S-TRLP, HDLZ, and LP-IR emerging as the most robust candidate signals. These findings are hypothesis-generating and warrant validation in larger, sex-balanced cohorts. Trial registration Not applicable.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) conducted a cohort in Chronic or hospitalized heart failure (n=867). Serially measured NMR-derived lipid and metabolic biomarkers (45 biomarkers including S-TRLP, HDLZ, LP-IR) and biological sex vs. Male vs female biological sex (sex-by-biomarker interaction) was evaluated on Cardiovascular death or worsening HF events in Bio-SHiFT; all-cause death or HF rehospitalization in TRIUMPH (HR 0.43, 95% CI 0.25-0.74). Serial NMR-derived biomarkers showed sex-dependent prognostic associations in HF for S-TRLP, HDLZ, and LP-IR.
Synapse has enriched 10 related papers. Consider them for comparative context: